Bio-Techne Corp. Stock
Price
Target price
€43.80
€43.80
0.460%
0.2
0.460%
€67.46
18.06.25 / Tradegate
WKN: A12ENG / Symbol: TECH / Name: Bio-Techne / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Bio-Techne Corp. Stock
The Bio-Techne Corp. stock is trending slightly upwards today, with an increase of €0.20 (0.460%) compared to yesterday's price.
With 9 Buy predictions and not the single Sell prediction the community is currently very high on Bio-Techne Corp..
With a target price of 67 € there is a hugely positive potential of 52.97% for Bio-Techne Corp. compared to the current price of 43.8 €.
So far the community has only identified positive things for Bio-Techne Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Bio-Techne Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Techne Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Techne Corp. | 0.460% | 0.000% | -0.455% | -36.978% | -36.978% | 123.185% | - |
| Bio-Rad Labs Inc. A | 1.560% | 2.594% | -6.965% | -23.389% | -34.511% | -53.817% | -49.335% |
| Neogen Corp. | -0.930% | -11.523% | -22.523% | -72.258% | -64.167% | - | - |
| Haemonetics Corp. | 2.540% | 1.681% | 0.000% | -23.418% | -19.868% | 6.140% | -18.792% |
Comments
Bio-Techne Co. (NASDAQ: TECH) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $75.00 price target on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $59.00 price target on the stock.
Show more
Ratings data for TECH provided by MarketBeat